Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daria J Hazuda

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Current Opinion in HIV and AIDS|August 9, 2012
HIV integrase as a target for antiretroviral therapyDaria J Hazuda
Current Opinion in HIV and AIDS|April 18, 2009
Inhibitors of human immunodeficiency virus type I integrationDaria J Hazuda
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|January 12, 2011
Resistance to inhibitors of the human immunodeficiency virus type 1 integrationDaria J Hazuda
Cold Spring Harbor Perspectives in Medicine|April 5, 2012
HIV-1 antiretroviral drug therapyEric J Arts, Daria J Hazuda
Current Opinion in HIV and AIDS|March 1, 2013
Combined approaches for HIV cureDavid M Margolis, Daria J Hazuda
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 26, 2004
HIV resistance to the fusion inhibitor enfuvirtide: mechanisms and clinical implicationsMichael D Miller, Daria J Hazuda
ACS Infectious Diseases|March 9, 2022
Call for Papers: Drug Resistance in Infectious Diseases and BeyondCelia A Schiffer, Daria J Hazuda
Current Opinion in Virology|August 17, 2014
Resistance to HIV integrase strand transfer inhibitors: in vitro findings and clinical consequencesJay A Grobler, Daria J Hazuda
Methods (San Diego, Calif.)|March 17, 2009
Scintillation proximity assays for mechanistic and pharmacological analyses of HIV-1 integrationJay A Grobler, Kara A Stillmock, Daria J Hazuda
Journal of Virology|August 3, 2007
c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoterGuochun Jiang, Amy Espeseth, Daria J Hazuda, et al.
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Current Opinion in HIV and AIDS|August 9, 2012
HIV integrase as a target for antiretroviral therapyDaria J Hazuda
Current Opinion in HIV and AIDS|April 18, 2009
Inhibitors of human immunodeficiency virus type I integrationDaria J Hazuda
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|January 12, 2011
Resistance to inhibitors of the human immunodeficiency virus type 1 integrationDaria J Hazuda
Cold Spring Harbor Perspectives in Medicine|April 5, 2012
HIV-1 antiretroviral drug therapyEric J Arts, Daria J Hazuda
Current Opinion in HIV and AIDS|March 1, 2013
Combined approaches for HIV cureDavid M Margolis, Daria J Hazuda
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 26, 2004
HIV resistance to the fusion inhibitor enfuvirtide: mechanisms and clinical implicationsMichael D Miller, Daria J Hazuda
ACS Infectious Diseases|March 9, 2022
Call for Papers: Drug Resistance in Infectious Diseases and BeyondCelia A Schiffer, Daria J Hazuda
Current Opinion in Virology|August 17, 2014
Resistance to HIV integrase strand transfer inhibitors: in vitro findings and clinical consequencesJay A Grobler, Daria J Hazuda
Methods (San Diego, Calif.)|March 17, 2009
Scintillation proximity assays for mechanistic and pharmacological analyses of HIV-1 integrationJay A Grobler, Kara A Stillmock, Daria J Hazuda
Journal of Virology|August 3, 2007
c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoterGuochun Jiang, Amy Espeseth, Daria J Hazuda, et al.
Pageof 14